Drug Name: Rezzayo
Indications: To treat candidemia and invasive candidiasis.
Active Ingredient: Rezafungin
Company: Melinta Therapeutics
Approval Date: 3/22/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217417s000lbl.pdf